Value of FDG-PET in the management of non-small cell lung cancer
- 1 January 2003
- journal article
- review article
- Published by Elsevier in European Journal of Radiology
- Vol. 45 (1) , 49-59
- https://doi.org/10.1016/s0720-048x(02)00282-6
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- FDG Positron Emission Tomography in the Diagnosis of Peripheral Pulmonary Focal LesionsThe Thoracic and Cardiovascular Surgeon, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.American Journal of Roentgenology, 1997
- Distribution of distant metastases from newly diagnosed non-small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935Cancer, 1996
- Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Satellite PET and lung cancerNuclear Medicine Communications, 1993
- The solitary pulmonary nodule.BMJ, 1989
- Non-small cell lung carcinoma adrenal metastases computed tomography and percutaneous needle biopsy in their diagnosisCancer, 1984
- Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinomaAmerican Journal of Roentgenology, 1982